https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-03-01 / Eksp. Onkol. 2004 Mar;26(1):67-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-03-01 / Eksp. Onkol. 2004 Mar;26(1):67-702004-03-01 00:00:002004-03-01 00:00:00Enhancement of antitumor response to sarcoma 45 in rats by combination of whole-body hyperthermia and interleukin-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-03-01 / 2004 Mar;41(Pt 2):138-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-03-01 / 2004 Mar;41(Pt 2):138-412004-03-01 00:00:002004-03-01 00:00:00Micronutrient concentrations in patients with malignant disease: effect of the inflammatory response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-03-01 / Int. J. Oncol. 2004 Mar;24(3):623-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-03-01 / Int. J. Oncol. 2004 Mar;24(3):623-342004-03-01 00:00:002020-06-23 09:42:15Importance of serine 200 for functional activities of the hemagglutinin-neuraminidase protein of Newcastle Disease Virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-02-25 / Cancer Immunol Immunother 2004 Jul;53(7):633-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-02-25 / Cancer Immunol Immunother 2004 Jul;53(7):633-412004-02-25 00:00:002023-03-07 13:15:18Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-02-01 / J. Gastrointest. Surg. 2004 Feb;8(2):175-81; discussion 181-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-02-01 / J. Gastrointest. Surg. 2004 Feb;8(2):175-81; discussion 181-22004-02-01 00:00:002019-02-15 09:23:51Dendritic cells pulsed with pancreatic cancer total tumor RNA generate specific antipancreatic cancer T cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-02-01 / Curr. Opin. Obstet. Gynecol. 2004 Feb;16(1):87-92
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-02-01 / Curr. Opin. Obstet. Gynecol. 2004 Feb;16(1):87-922004-02-01 00:00:002004-02-01 00:00:00Immunological treatment of ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-01-01 / Cytotherapy 2004;6(2):154-63
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-01-01 / Cytotherapy 2004;6(2):154-632004-01-01 00:00:002019-02-15 08:50:27The immune response to breast cancer, and the case for DC immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-01-01 / Cytotherapy 2004;6(1):62-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-01-01 / Cytotherapy 2004;6(1):62-72004-01-01 00:00:002019-02-15 08:51:06DC-based immunotherapy of B-cell malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-01-01 / Int. J. Mol. Med. 2004 Jan;13(1):33-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-01-01 / Int. J. Mol. Med. 2004 Jan;13(1):33-92004-01-01 00:00:002019-02-15 08:53:30Thyroglobulin-pulsed human monocyte-derived dendritic cells induce CD4+ T cell activation
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-01-01 / Breast Dis 2004;20:65-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-01-01 / Breast Dis 2004;20:65-712004-01-01 00:00:002004-01-01 00:00:00Dendritic cell-based therapeutics for breast cancer
